Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Anixa Biosciences Inc ANIX

Healthcare Biotechnology
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well as other forms of breast cancer and the development of a preventative vaccine against ovarian cancer. Its therapeutics programs include the development of a chimeric endocrine receptor T cell therapy, a novel form of chimeric antigen receptor T cell (CAR-T) technology, initially focused on treating ovarian cancer, which is being developed by its subsidiary, Certainty Therapeutics, Inc. (Certainty). Certainty is developing immuno-therapy drugs against cancer. The Company’s vaccine portfolio consists of technology focused on the immunization against specific retired proteins.


NDAQ:ANIX - Post by User

Anixa Biosciences Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(265)
•••
Post by whytestockson Aug 26, 2024 12:02pm
17 Views
Post# 36196154

Anixa Biosciences to Present at the H.C. Wainwright 26th Ann

Anixa Biosciences to Present at the H.C. Wainwright 26th Ann
Breaking News: $ANIX Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAnixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire SAN JOSE, Calif. , Aug. 26, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatme...ANIX - Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities